Global Pirfenidone API Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Pirfenidone API Industry Forecast” looks at past sales and reviews total world Pirfenidone API sales in 2022, providing a comprehensive analysis by region and market sector of projected Pirfenidone API sales for 2023 through 2029. With Pirfenidone API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pirfenidone API industry.
This Insight Report provides a comprehensive analysis of the global Pirfenidone API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pirfenidone API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pirfenidone API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pirfenidone API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pirfenidone API.
The global Pirfenidone API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pirfenidone API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pirfenidone API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pirfenidone API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pirfenidone API players cover Xian Libang Pharmaceutical, Metrochem API, Veranova, Alembic Pharmaceuticals Limited, Apotex Pharmachem, Aurobindo Pharma Limited, Cambrex Corporation, Glenmark Pharmaceuticals and Macleods Pharmaceuticals Limited, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pirfenidone API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Pirfenidone API market?
What factors are driving Pirfenidone API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pirfenidone API market opportunities vary by end market size?
How does Pirfenidone API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Pirfenidone API Industry Forecast” looks at past sales and reviews total world Pirfenidone API sales in 2022, providing a comprehensive analysis by region and market sector of projected Pirfenidone API sales for 2023 through 2029. With Pirfenidone API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pirfenidone API industry.
This Insight Report provides a comprehensive analysis of the global Pirfenidone API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pirfenidone API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pirfenidone API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pirfenidone API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pirfenidone API.
The global Pirfenidone API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pirfenidone API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pirfenidone API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pirfenidone API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pirfenidone API players cover Xian Libang Pharmaceutical, Metrochem API, Veranova, Alembic Pharmaceuticals Limited, Apotex Pharmachem, Aurobindo Pharma Limited, Cambrex Corporation, Glenmark Pharmaceuticals and Macleods Pharmaceuticals Limited, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pirfenidone API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- 0.99
- 0.995
- 0.999
- Others
- Tablets
- Capsules
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Xian Libang Pharmaceutical
- Metrochem API
- Veranova
- Alembic Pharmaceuticals Limited
- Apotex Pharmachem
- Aurobindo Pharma Limited
- Cambrex Corporation
- Glenmark Pharmaceuticals
- Macleods Pharmaceuticals Limited
- Mehta API
- Natco Pharma Limited
- Optimus Pharma
- Shilpa Medicare
What is the 10-year outlook for the global Pirfenidone API market?
What factors are driving Pirfenidone API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pirfenidone API market opportunities vary by end market size?
How does Pirfenidone API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pirfenidone API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pirfenidone API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pirfenidone API by Country/Region, 2018, 2022 & 2029
2.2 Pirfenidone API Segment by Type
2.2.1 0.99
2.2.2 0.995
2.2.3 0.999
2.2.4 Others
2.3 Pirfenidone API Sales by Type
2.3.1 Global Pirfenidone API Sales Market Share by Type (2018-2023)
2.3.2 Global Pirfenidone API Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pirfenidone API Sale Price by Type (2018-2023)
2.4 Pirfenidone API Segment by Application
2.4.1 Tablets
2.4.2 Capsules
2.4.3 Others
2.5 Pirfenidone API Sales by Application
2.5.1 Global Pirfenidone API Sale Market Share by Application (2018-2023)
2.5.2 Global Pirfenidone API Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pirfenidone API Sale Price by Application (2018-2023)
3 GLOBAL PIRFENIDONE API BY COMPANY
3.1 Global Pirfenidone API Breakdown Data by Company
3.1.1 Global Pirfenidone API Annual Sales by Company (2018-2023)
3.1.2 Global Pirfenidone API Sales Market Share by Company (2018-2023)
3.2 Global Pirfenidone API Annual Revenue by Company (2018-2023)
3.2.1 Global Pirfenidone API Revenue by Company (2018-2023)
3.2.2 Global Pirfenidone API Revenue Market Share by Company (2018-2023)
3.3 Global Pirfenidone API Sale Price by Company
3.4 Key Manufacturers Pirfenidone API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pirfenidone API Product Location Distribution
3.4.2 Players Pirfenidone API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PIRFENIDONE API BY GEOGRAPHIC REGION
4.1 World Historic Pirfenidone API Market Size by Geographic Region (2018-2023)
4.1.1 Global Pirfenidone API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pirfenidone API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pirfenidone API Market Size by Country/Region (2018-2023)
4.2.1 Global Pirfenidone API Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pirfenidone API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pirfenidone API Sales Growth
4.4 APAC Pirfenidone API Sales Growth
4.5 Europe Pirfenidone API Sales Growth
4.6 Middle East & Africa Pirfenidone API Sales Growth
5 AMERICAS
5.1 Americas Pirfenidone API Sales by Country
5.1.1 Americas Pirfenidone API Sales by Country (2018-2023)
5.1.2 Americas Pirfenidone API Revenue by Country (2018-2023)
5.2 Americas Pirfenidone API Sales by Type
5.3 Americas Pirfenidone API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pirfenidone API Sales by Region
6.1.1 APAC Pirfenidone API Sales by Region (2018-2023)
6.1.2 APAC Pirfenidone API Revenue by Region (2018-2023)
6.2 APAC Pirfenidone API Sales by Type
6.3 APAC Pirfenidone API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pirfenidone API by Country
7.1.1 Europe Pirfenidone API Sales by Country (2018-2023)
7.1.2 Europe Pirfenidone API Revenue by Country (2018-2023)
7.2 Europe Pirfenidone API Sales by Type
7.3 Europe Pirfenidone API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pirfenidone API by Country
8.1.1 Middle East & Africa Pirfenidone API Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pirfenidone API Revenue by Country (2018-2023)
8.2 Middle East & Africa Pirfenidone API Sales by Type
8.3 Middle East & Africa Pirfenidone API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pirfenidone API
10.3 Manufacturing Process Analysis of Pirfenidone API
10.4 Industry Chain Structure of Pirfenidone API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pirfenidone API Distributors
11.3 Pirfenidone API Customer
12 WORLD FORECAST REVIEW FOR PIRFENIDONE API BY GEOGRAPHIC REGION
12.1 Global Pirfenidone API Market Size Forecast by Region
12.1.1 Global Pirfenidone API Forecast by Region (2024-2029)
12.1.2 Global Pirfenidone API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pirfenidone API Forecast by Type
12.7 Global Pirfenidone API Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Xian Libang Pharmaceutical
13.1.1 Xian Libang Pharmaceutical Company Information
13.1.2 Xian Libang Pharmaceutical Pirfenidone API Product Portfolios and Specifications
13.1.3 Xian Libang Pharmaceutical Pirfenidone API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Xian Libang Pharmaceutical Main Business Overview
13.1.5 Xian Libang Pharmaceutical Latest Developments
13.2 Metrochem API
13.2.1 Metrochem API Company Information
13.2.2 Metrochem API Pirfenidone API Product Portfolios and Specifications
13.2.3 Metrochem API Pirfenidone API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Metrochem API Main Business Overview
13.2.5 Metrochem API Latest Developments
13.3 Veranova
13.3.1 Veranova Company Information
13.3.2 Veranova Pirfenidone API Product Portfolios and Specifications
13.3.3 Veranova Pirfenidone API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Veranova Main Business Overview
13.3.5 Veranova Latest Developments
13.4 Alembic Pharmaceuticals Limited
13.4.1 Alembic Pharmaceuticals Limited Company Information
13.4.2 Alembic Pharmaceuticals Limited Pirfenidone API Product Portfolios and Specifications
13.4.3 Alembic Pharmaceuticals Limited Pirfenidone API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Alembic Pharmaceuticals Limited Main Business Overview
13.4.5 Alembic Pharmaceuticals Limited Latest Developments
13.5 Apotex Pharmachem
13.5.1 Apotex Pharmachem Company Information
13.5.2 Apotex Pharmachem Pirfenidone API Product Portfolios and Specifications
13.5.3 Apotex Pharmachem Pirfenidone API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Apotex Pharmachem Main Business Overview
13.5.5 Apotex Pharmachem Latest Developments
13.6 Aurobindo Pharma Limited
13.6.1 Aurobindo Pharma Limited Company Information
13.6.2 Aurobindo Pharma Limited Pirfenidone API Product Portfolios and Specifications
13.6.3 Aurobindo Pharma Limited Pirfenidone API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Aurobindo Pharma Limited Main Business Overview
13.6.5 Aurobindo Pharma Limited Latest Developments
13.7 Cambrex Corporation
13.7.1 Cambrex Corporation Company Information
13.7.2 Cambrex Corporation Pirfenidone API Product Portfolios and Specifications
13.7.3 Cambrex Corporation Pirfenidone API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Cambrex Corporation Main Business Overview
13.7.5 Cambrex Corporation Latest Developments
13.8 Glenmark Pharmaceuticals
13.8.1 Glenmark Pharmaceuticals Company Information
13.8.2 Glenmark Pharmaceuticals Pirfenidone API Product Portfolios and Specifications
13.8.3 Glenmark Pharmaceuticals Pirfenidone API Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Glenmark Pharmaceuticals Main Business Overview
13.8.5 Glenmark Pharmaceuticals Latest Developments
13.9 Macleods Pharmaceuticals Limited
13.9.1 Macleods Pharmaceuticals Limited Company Information
13.9.2 Macleods Pharmaceuticals Limited Pirfenidone API Product Portfolios and Specifications
13.9.3 Macleods Pharmaceuticals Limited Pirfenidone API Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Macleods Pharmaceuticals Limited Main Business Overview
13.9.5 Macleods Pharmaceuticals Limited Latest Developments
13.10 Mehta API
13.10.1 Mehta API Company Information
13.10.2 Mehta API Pirfenidone API Product Portfolios and Specifications
13.10.3 Mehta API Pirfenidone API Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Mehta API Main Business Overview
13.10.5 Mehta API Latest Developments
13.11 Natco Pharma Limited
13.11.1 Natco Pharma Limited Company Information
13.11.2 Natco Pharma Limited Pirfenidone API Product Portfolios and Specifications
13.11.3 Natco Pharma Limited Pirfenidone API Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Natco Pharma Limited Main Business Overview
13.11.5 Natco Pharma Limited Latest Developments
13.12 Optimus Pharma
13.12.1 Optimus Pharma Company Information
13.12.2 Optimus Pharma Pirfenidone API Product Portfolios and Specifications
13.12.3 Optimus Pharma Pirfenidone API Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Optimus Pharma Main Business Overview
13.12.5 Optimus Pharma Latest Developments
13.13 Shilpa Medicare
13.13.1 Shilpa Medicare Company Information
13.13.2 Shilpa Medicare Pirfenidone API Product Portfolios and Specifications
13.13.3 Shilpa Medicare Pirfenidone API Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Shilpa Medicare Main Business Overview
13.13.5 Shilpa Medicare Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pirfenidone API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pirfenidone API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pirfenidone API by Country/Region, 2018, 2022 & 2029
2.2 Pirfenidone API Segment by Type
2.2.1 0.99
2.2.2 0.995
2.2.3 0.999
2.2.4 Others
2.3 Pirfenidone API Sales by Type
2.3.1 Global Pirfenidone API Sales Market Share by Type (2018-2023)
2.3.2 Global Pirfenidone API Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pirfenidone API Sale Price by Type (2018-2023)
2.4 Pirfenidone API Segment by Application
2.4.1 Tablets
2.4.2 Capsules
2.4.3 Others
2.5 Pirfenidone API Sales by Application
2.5.1 Global Pirfenidone API Sale Market Share by Application (2018-2023)
2.5.2 Global Pirfenidone API Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pirfenidone API Sale Price by Application (2018-2023)
3 GLOBAL PIRFENIDONE API BY COMPANY
3.1 Global Pirfenidone API Breakdown Data by Company
3.1.1 Global Pirfenidone API Annual Sales by Company (2018-2023)
3.1.2 Global Pirfenidone API Sales Market Share by Company (2018-2023)
3.2 Global Pirfenidone API Annual Revenue by Company (2018-2023)
3.2.1 Global Pirfenidone API Revenue by Company (2018-2023)
3.2.2 Global Pirfenidone API Revenue Market Share by Company (2018-2023)
3.3 Global Pirfenidone API Sale Price by Company
3.4 Key Manufacturers Pirfenidone API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pirfenidone API Product Location Distribution
3.4.2 Players Pirfenidone API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PIRFENIDONE API BY GEOGRAPHIC REGION
4.1 World Historic Pirfenidone API Market Size by Geographic Region (2018-2023)
4.1.1 Global Pirfenidone API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pirfenidone API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pirfenidone API Market Size by Country/Region (2018-2023)
4.2.1 Global Pirfenidone API Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pirfenidone API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pirfenidone API Sales Growth
4.4 APAC Pirfenidone API Sales Growth
4.5 Europe Pirfenidone API Sales Growth
4.6 Middle East & Africa Pirfenidone API Sales Growth
5 AMERICAS
5.1 Americas Pirfenidone API Sales by Country
5.1.1 Americas Pirfenidone API Sales by Country (2018-2023)
5.1.2 Americas Pirfenidone API Revenue by Country (2018-2023)
5.2 Americas Pirfenidone API Sales by Type
5.3 Americas Pirfenidone API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pirfenidone API Sales by Region
6.1.1 APAC Pirfenidone API Sales by Region (2018-2023)
6.1.2 APAC Pirfenidone API Revenue by Region (2018-2023)
6.2 APAC Pirfenidone API Sales by Type
6.3 APAC Pirfenidone API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pirfenidone API by Country
7.1.1 Europe Pirfenidone API Sales by Country (2018-2023)
7.1.2 Europe Pirfenidone API Revenue by Country (2018-2023)
7.2 Europe Pirfenidone API Sales by Type
7.3 Europe Pirfenidone API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pirfenidone API by Country
8.1.1 Middle East & Africa Pirfenidone API Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pirfenidone API Revenue by Country (2018-2023)
8.2 Middle East & Africa Pirfenidone API Sales by Type
8.3 Middle East & Africa Pirfenidone API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pirfenidone API
10.3 Manufacturing Process Analysis of Pirfenidone API
10.4 Industry Chain Structure of Pirfenidone API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pirfenidone API Distributors
11.3 Pirfenidone API Customer
12 WORLD FORECAST REVIEW FOR PIRFENIDONE API BY GEOGRAPHIC REGION
12.1 Global Pirfenidone API Market Size Forecast by Region
12.1.1 Global Pirfenidone API Forecast by Region (2024-2029)
12.1.2 Global Pirfenidone API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pirfenidone API Forecast by Type
12.7 Global Pirfenidone API Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Xian Libang Pharmaceutical
13.1.1 Xian Libang Pharmaceutical Company Information
13.1.2 Xian Libang Pharmaceutical Pirfenidone API Product Portfolios and Specifications
13.1.3 Xian Libang Pharmaceutical Pirfenidone API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Xian Libang Pharmaceutical Main Business Overview
13.1.5 Xian Libang Pharmaceutical Latest Developments
13.2 Metrochem API
13.2.1 Metrochem API Company Information
13.2.2 Metrochem API Pirfenidone API Product Portfolios and Specifications
13.2.3 Metrochem API Pirfenidone API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Metrochem API Main Business Overview
13.2.5 Metrochem API Latest Developments
13.3 Veranova
13.3.1 Veranova Company Information
13.3.2 Veranova Pirfenidone API Product Portfolios and Specifications
13.3.3 Veranova Pirfenidone API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Veranova Main Business Overview
13.3.5 Veranova Latest Developments
13.4 Alembic Pharmaceuticals Limited
13.4.1 Alembic Pharmaceuticals Limited Company Information
13.4.2 Alembic Pharmaceuticals Limited Pirfenidone API Product Portfolios and Specifications
13.4.3 Alembic Pharmaceuticals Limited Pirfenidone API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Alembic Pharmaceuticals Limited Main Business Overview
13.4.5 Alembic Pharmaceuticals Limited Latest Developments
13.5 Apotex Pharmachem
13.5.1 Apotex Pharmachem Company Information
13.5.2 Apotex Pharmachem Pirfenidone API Product Portfolios and Specifications
13.5.3 Apotex Pharmachem Pirfenidone API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Apotex Pharmachem Main Business Overview
13.5.5 Apotex Pharmachem Latest Developments
13.6 Aurobindo Pharma Limited
13.6.1 Aurobindo Pharma Limited Company Information
13.6.2 Aurobindo Pharma Limited Pirfenidone API Product Portfolios and Specifications
13.6.3 Aurobindo Pharma Limited Pirfenidone API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Aurobindo Pharma Limited Main Business Overview
13.6.5 Aurobindo Pharma Limited Latest Developments
13.7 Cambrex Corporation
13.7.1 Cambrex Corporation Company Information
13.7.2 Cambrex Corporation Pirfenidone API Product Portfolios and Specifications
13.7.3 Cambrex Corporation Pirfenidone API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Cambrex Corporation Main Business Overview
13.7.5 Cambrex Corporation Latest Developments
13.8 Glenmark Pharmaceuticals
13.8.1 Glenmark Pharmaceuticals Company Information
13.8.2 Glenmark Pharmaceuticals Pirfenidone API Product Portfolios and Specifications
13.8.3 Glenmark Pharmaceuticals Pirfenidone API Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Glenmark Pharmaceuticals Main Business Overview
13.8.5 Glenmark Pharmaceuticals Latest Developments
13.9 Macleods Pharmaceuticals Limited
13.9.1 Macleods Pharmaceuticals Limited Company Information
13.9.2 Macleods Pharmaceuticals Limited Pirfenidone API Product Portfolios and Specifications
13.9.3 Macleods Pharmaceuticals Limited Pirfenidone API Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Macleods Pharmaceuticals Limited Main Business Overview
13.9.5 Macleods Pharmaceuticals Limited Latest Developments
13.10 Mehta API
13.10.1 Mehta API Company Information
13.10.2 Mehta API Pirfenidone API Product Portfolios and Specifications
13.10.3 Mehta API Pirfenidone API Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Mehta API Main Business Overview
13.10.5 Mehta API Latest Developments
13.11 Natco Pharma Limited
13.11.1 Natco Pharma Limited Company Information
13.11.2 Natco Pharma Limited Pirfenidone API Product Portfolios and Specifications
13.11.3 Natco Pharma Limited Pirfenidone API Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Natco Pharma Limited Main Business Overview
13.11.5 Natco Pharma Limited Latest Developments
13.12 Optimus Pharma
13.12.1 Optimus Pharma Company Information
13.12.2 Optimus Pharma Pirfenidone API Product Portfolios and Specifications
13.12.3 Optimus Pharma Pirfenidone API Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Optimus Pharma Main Business Overview
13.12.5 Optimus Pharma Latest Developments
13.13 Shilpa Medicare
13.13.1 Shilpa Medicare Company Information
13.13.2 Shilpa Medicare Pirfenidone API Product Portfolios and Specifications
13.13.3 Shilpa Medicare Pirfenidone API Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Shilpa Medicare Main Business Overview
13.13.5 Shilpa Medicare Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pirfenidone API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pirfenidone API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 0.99
Table 4. Major Players of 0.995
Table 5. Major Players of 0.999
Table 6. Major Players of Others
Table 7. Global Pirfenidone API Sales by Type (2018-2023) & (Tons)
Table 8. Global Pirfenidone API Sales Market Share by Type (2018-2023)
Table 9. Global Pirfenidone API Revenue by Type (2018-2023) & ($ million)
Table 10. Global Pirfenidone API Revenue Market Share by Type (2018-2023)
Table 11. Global Pirfenidone API Sale Price by Type (2018-2023) & (US$/Kg)
Table 12. Global Pirfenidone API Sales by Application (2018-2023) & (Tons)
Table 13. Global Pirfenidone API Sales Market Share by Application (2018-2023)
Table 14. Global Pirfenidone API Revenue by Application (2018-2023)
Table 15. Global Pirfenidone API Revenue Market Share by Application (2018-2023)
Table 16. Global Pirfenidone API Sale Price by Application (2018-2023) & (US$/Kg)
Table 17. Global Pirfenidone API Sales by Company (2018-2023) & (Tons)
Table 18. Global Pirfenidone API Sales Market Share by Company (2018-2023)
Table 19. Global Pirfenidone API Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Pirfenidone API Revenue Market Share by Company (2018-2023)
Table 21. Global Pirfenidone API Sale Price by Company (2018-2023) & (US$/Kg)
Table 22. Key Manufacturers Pirfenidone API Producing Area Distribution and Sales Area
Table 23. Players Pirfenidone API Products Offered
Table 24. Pirfenidone API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Pirfenidone API Sales by Geographic Region (2018-2023) & (Tons)
Table 28. Global Pirfenidone API Sales Market Share Geographic Region (2018-2023)
Table 29. Global Pirfenidone API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Pirfenidone API Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Pirfenidone API Sales by Country/Region (2018-2023) & (Tons)
Table 32. Global Pirfenidone API Sales Market Share by Country/Region (2018-2023)
Table 33. Global Pirfenidone API Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Pirfenidone API Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Pirfenidone API Sales by Country (2018-2023) & (Tons)
Table 36. Americas Pirfenidone API Sales Market Share by Country (2018-2023)
Table 37. Americas Pirfenidone API Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Pirfenidone API Revenue Market Share by Country (2018-2023)
Table 39. Americas Pirfenidone API Sales by Type (2018-2023) & (Tons)
Table 40. Americas Pirfenidone API Sales by Application (2018-2023) & (Tons)
Table 41. APAC Pirfenidone API Sales by Region (2018-2023) & (Tons)
Table 42. APAC Pirfenidone API Sales Market Share by Region (2018-2023)
Table 43. APAC Pirfenidone API Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Pirfenidone API Revenue Market Share by Region (2018-2023)
Table 45. APAC Pirfenidone API Sales by Type (2018-2023) & (Tons)
Table 46. APAC Pirfenidone API Sales by Application (2018-2023) & (Tons)
Table 47. Europe Pirfenidone API Sales by Country (2018-2023) & (Tons)
Table 48. Europe Pirfenidone API Sales Market Share by Country (2018-2023)
Table 49. Europe Pirfenidone API Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Pirfenidone API Revenue Market Share by Country (2018-2023)
Table 51. Europe Pirfenidone API Sales by Type (2018-2023) & (Tons)
Table 52. Europe Pirfenidone API Sales by Application (2018-2023) & (Tons)
Table 53. Middle East & Africa Pirfenidone API Sales by Country (2018-2023) & (Tons)
Table 54. Middle East & Africa Pirfenidone API Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Pirfenidone API Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Pirfenidone API Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Pirfenidone API Sales by Type (2018-2023) & (Tons)
Table 58. Middle East & Africa Pirfenidone API Sales by Application (2018-2023) & (Tons)
Table 59. Key Market Drivers & Growth Opportunities of Pirfenidone API
Table 60. Key Market Challenges & Risks of Pirfenidone API
Table 61. Key Industry Trends of Pirfenidone API
Table 62. Pirfenidone API Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Pirfenidone API Distributors List
Table 65. Pirfenidone API Customer List
Table 66. Global Pirfenidone API Sales Forecast by Region (2024-2029) & (Tons)
Table 67. Global Pirfenidone API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Pirfenidone API Sales Forecast by Country (2024-2029) & (Tons)
Table 69. Americas Pirfenidone API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Pirfenidone API Sales Forecast by Region (2024-2029) & (Tons)
Table 71. APAC Pirfenidone API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Pirfenidone API Sales Forecast by Country (2024-2029) & (Tons)
Table 73. Europe Pirfenidone API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Pirfenidone API Sales Forecast by Country (2024-2029) & (Tons)
Table 75. Middle East & Africa Pirfenidone API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Pirfenidone API Sales Forecast by Type (2024-2029) & (Tons)
Table 77. Global Pirfenidone API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Pirfenidone API Sales Forecast by Application (2024-2029) & (Tons)
Table 79. Global Pirfenidone API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Xian Libang Pharmaceutical Basic Information, Pirfenidone API Manufacturing Base, Sales Area and Its Competitors
Table 81. Xian Libang Pharmaceutical Pirfenidone API Product Portfolios and Specifications
Table 82. Xian Libang Pharmaceutical Pirfenidone API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 83. Xian Libang Pharmaceutical Main Business
Table 84. Xian Libang Pharmaceutical Latest Developments
Table 85. Metrochem API Basic Information, Pirfenidone API Manufacturing Base, Sales Area and Its Competitors
Table 86. Metrochem API Pirfenidone API Product Portfolios and Specifications
Table 87. Metrochem API Pirfenidone API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 88. Metrochem API Main Business
Table 89. Metrochem API Latest Developments
Table 90. Veranova Basic Information, Pirfenidone API Manufacturing Base, Sales Area and Its Competitors
Table 91. Veranova Pirfenidone API Product Portfolios and Specifications
Table 92. Veranova Pirfenidone API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 93. Veranova Main Business
Table 94. Veranova Latest Developments
Table 95. Alembic Pharmaceuticals Limited Basic Information, Pirfenidone API Manufacturing Base, Sales Area and Its Competitors
Table 96. Alembic Pharmaceuticals Limited Pirfenidone API Product Portfolios and Specifications
Table 97. Alembic Pharmaceuticals Limited Pirfenidone API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 98. Alembic Pharmaceuticals Limited Main Business
Table 99. Alembic Pharmaceuticals Limited Latest Developments
Table 100. Apotex Pharmachem Basic Information, Pirfenidone API Manufacturing Base, Sales Area and Its Competitors
Table 101. Apotex Pharmachem Pirfenidone API Product Portfolios and Specifications
Table 102. Apotex Pharmachem Pirfenidone API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 103. Apotex Pharmachem Main Business
Table 104. Apotex Pharmachem Latest Developments
Table 105. Aurobindo Pharma Limited Basic Information, Pirfenidone API Manufacturing Base, Sales Area and Its Competitors
Table 106. Aurobindo Pharma Limited Pirfenidone API Product Portfolios and Specifications
Table 107. Aurobindo Pharma Limited Pirfenidone API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 108. Aurobindo Pharma Limited Main Business
Table 109. Aurobindo Pharma Limited Latest Developments
Table 110. Cambrex Corporation Basic Information, Pirfenidone API Manufacturing Base, Sales Area and Its Competitors
Table 111. Cambrex Corporation Pirfenidone API Product Portfolios and Specifications
Table 112. Cambrex Corporation Pirfenidone API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 113. Cambrex Corporation Main Business
Table 114. Cambrex Corporation Latest Developments
Table 115. Glenmark Pharmaceuticals Basic Information, Pirfenidone API Manufacturing Base, Sales Area and Its Competitors
Table 116. Glenmark Pharmaceuticals Pirfenidone API Product Portfolios and Specifications
Table 117. Glenmark Pharmaceuticals Pirfenidone API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 118. Glenmark Pharmaceuticals Main Business
Table 119. Glenmark Pharmaceuticals Latest Developments
Table 120. Macleods Pharmaceuticals Limited Basic Information, Pirfenidone API Manufacturing Base, Sales Area and Its Competitors
Table 121. Macleods Pharmaceuticals Limited Pirfenidone API Product Portfolios and Specifications
Table 122. Macleods Pharmaceuticals Limited Pirfenidone API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 123. Macleods Pharmaceuticals Limited Main Business
Table 124. Macleods Pharmaceuticals Limited Latest Developments
Table 125. Mehta API Basic Information, Pirfenidone API Manufacturing Base, Sales Area and Its Competitors
Table 126. Mehta API Pirfenidone API Product Portfolios and Specifications
Table 127. Mehta API Pirfenidone API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 128. Mehta API Main Business
Table 129. Mehta API Latest Developments
Table 130. Natco Pharma Limited Basic Information, Pirfenidone API Manufacturing Base, Sales Area and Its Competitors
Table 131. Natco Pharma Limited Pirfenidone API Product Portfolios and Specifications
Table 132. Natco Pharma Limited Pirfenidone API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 133. Natco Pharma Limited Main Business
Table 134. Natco Pharma Limited Latest Developments
Table 135. Optimus Pharma Basic Information, Pirfenidone API Manufacturing Base, Sales Area and Its Competitors
Table 136. Optimus Pharma Pirfenidone API Product Portfolios and Specifications
Table 137. Optimus Pharma Pirfenidone API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 138. Optimus Pharma Main Business
Table 139. Optimus Pharma Latest Developments
Table 140. Shilpa Medicare Basic Information, Pirfenidone API Manufacturing Base, Sales Area and Its Competitors
Table 141. Shilpa Medicare Pirfenidone API Product Portfolios and Specifications
Table 142. Shilpa Medicare Pirfenidone API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 143. Shilpa Medicare Main Business
Table 144. Shilpa Medicare Latest Developments
Table 1. Pirfenidone API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pirfenidone API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 0.99
Table 4. Major Players of 0.995
Table 5. Major Players of 0.999
Table 6. Major Players of Others
Table 7. Global Pirfenidone API Sales by Type (2018-2023) & (Tons)
Table 8. Global Pirfenidone API Sales Market Share by Type (2018-2023)
Table 9. Global Pirfenidone API Revenue by Type (2018-2023) & ($ million)
Table 10. Global Pirfenidone API Revenue Market Share by Type (2018-2023)
Table 11. Global Pirfenidone API Sale Price by Type (2018-2023) & (US$/Kg)
Table 12. Global Pirfenidone API Sales by Application (2018-2023) & (Tons)
Table 13. Global Pirfenidone API Sales Market Share by Application (2018-2023)
Table 14. Global Pirfenidone API Revenue by Application (2018-2023)
Table 15. Global Pirfenidone API Revenue Market Share by Application (2018-2023)
Table 16. Global Pirfenidone API Sale Price by Application (2018-2023) & (US$/Kg)
Table 17. Global Pirfenidone API Sales by Company (2018-2023) & (Tons)
Table 18. Global Pirfenidone API Sales Market Share by Company (2018-2023)
Table 19. Global Pirfenidone API Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Pirfenidone API Revenue Market Share by Company (2018-2023)
Table 21. Global Pirfenidone API Sale Price by Company (2018-2023) & (US$/Kg)
Table 22. Key Manufacturers Pirfenidone API Producing Area Distribution and Sales Area
Table 23. Players Pirfenidone API Products Offered
Table 24. Pirfenidone API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Pirfenidone API Sales by Geographic Region (2018-2023) & (Tons)
Table 28. Global Pirfenidone API Sales Market Share Geographic Region (2018-2023)
Table 29. Global Pirfenidone API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Pirfenidone API Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Pirfenidone API Sales by Country/Region (2018-2023) & (Tons)
Table 32. Global Pirfenidone API Sales Market Share by Country/Region (2018-2023)
Table 33. Global Pirfenidone API Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Pirfenidone API Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Pirfenidone API Sales by Country (2018-2023) & (Tons)
Table 36. Americas Pirfenidone API Sales Market Share by Country (2018-2023)
Table 37. Americas Pirfenidone API Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Pirfenidone API Revenue Market Share by Country (2018-2023)
Table 39. Americas Pirfenidone API Sales by Type (2018-2023) & (Tons)
Table 40. Americas Pirfenidone API Sales by Application (2018-2023) & (Tons)
Table 41. APAC Pirfenidone API Sales by Region (2018-2023) & (Tons)
Table 42. APAC Pirfenidone API Sales Market Share by Region (2018-2023)
Table 43. APAC Pirfenidone API Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Pirfenidone API Revenue Market Share by Region (2018-2023)
Table 45. APAC Pirfenidone API Sales by Type (2018-2023) & (Tons)
Table 46. APAC Pirfenidone API Sales by Application (2018-2023) & (Tons)
Table 47. Europe Pirfenidone API Sales by Country (2018-2023) & (Tons)
Table 48. Europe Pirfenidone API Sales Market Share by Country (2018-2023)
Table 49. Europe Pirfenidone API Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Pirfenidone API Revenue Market Share by Country (2018-2023)
Table 51. Europe Pirfenidone API Sales by Type (2018-2023) & (Tons)
Table 52. Europe Pirfenidone API Sales by Application (2018-2023) & (Tons)
Table 53. Middle East & Africa Pirfenidone API Sales by Country (2018-2023) & (Tons)
Table 54. Middle East & Africa Pirfenidone API Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Pirfenidone API Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Pirfenidone API Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Pirfenidone API Sales by Type (2018-2023) & (Tons)
Table 58. Middle East & Africa Pirfenidone API Sales by Application (2018-2023) & (Tons)
Table 59. Key Market Drivers & Growth Opportunities of Pirfenidone API
Table 60. Key Market Challenges & Risks of Pirfenidone API
Table 61. Key Industry Trends of Pirfenidone API
Table 62. Pirfenidone API Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Pirfenidone API Distributors List
Table 65. Pirfenidone API Customer List
Table 66. Global Pirfenidone API Sales Forecast by Region (2024-2029) & (Tons)
Table 67. Global Pirfenidone API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Pirfenidone API Sales Forecast by Country (2024-2029) & (Tons)
Table 69. Americas Pirfenidone API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Pirfenidone API Sales Forecast by Region (2024-2029) & (Tons)
Table 71. APAC Pirfenidone API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Pirfenidone API Sales Forecast by Country (2024-2029) & (Tons)
Table 73. Europe Pirfenidone API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Pirfenidone API Sales Forecast by Country (2024-2029) & (Tons)
Table 75. Middle East & Africa Pirfenidone API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Pirfenidone API Sales Forecast by Type (2024-2029) & (Tons)
Table 77. Global Pirfenidone API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Pirfenidone API Sales Forecast by Application (2024-2029) & (Tons)
Table 79. Global Pirfenidone API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Xian Libang Pharmaceutical Basic Information, Pirfenidone API Manufacturing Base, Sales Area and Its Competitors
Table 81. Xian Libang Pharmaceutical Pirfenidone API Product Portfolios and Specifications
Table 82. Xian Libang Pharmaceutical Pirfenidone API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 83. Xian Libang Pharmaceutical Main Business
Table 84. Xian Libang Pharmaceutical Latest Developments
Table 85. Metrochem API Basic Information, Pirfenidone API Manufacturing Base, Sales Area and Its Competitors
Table 86. Metrochem API Pirfenidone API Product Portfolios and Specifications
Table 87. Metrochem API Pirfenidone API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 88. Metrochem API Main Business
Table 89. Metrochem API Latest Developments
Table 90. Veranova Basic Information, Pirfenidone API Manufacturing Base, Sales Area and Its Competitors
Table 91. Veranova Pirfenidone API Product Portfolios and Specifications
Table 92. Veranova Pirfenidone API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 93. Veranova Main Business
Table 94. Veranova Latest Developments
Table 95. Alembic Pharmaceuticals Limited Basic Information, Pirfenidone API Manufacturing Base, Sales Area and Its Competitors
Table 96. Alembic Pharmaceuticals Limited Pirfenidone API Product Portfolios and Specifications
Table 97. Alembic Pharmaceuticals Limited Pirfenidone API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 98. Alembic Pharmaceuticals Limited Main Business
Table 99. Alembic Pharmaceuticals Limited Latest Developments
Table 100. Apotex Pharmachem Basic Information, Pirfenidone API Manufacturing Base, Sales Area and Its Competitors
Table 101. Apotex Pharmachem Pirfenidone API Product Portfolios and Specifications
Table 102. Apotex Pharmachem Pirfenidone API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 103. Apotex Pharmachem Main Business
Table 104. Apotex Pharmachem Latest Developments
Table 105. Aurobindo Pharma Limited Basic Information, Pirfenidone API Manufacturing Base, Sales Area and Its Competitors
Table 106. Aurobindo Pharma Limited Pirfenidone API Product Portfolios and Specifications
Table 107. Aurobindo Pharma Limited Pirfenidone API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 108. Aurobindo Pharma Limited Main Business
Table 109. Aurobindo Pharma Limited Latest Developments
Table 110. Cambrex Corporation Basic Information, Pirfenidone API Manufacturing Base, Sales Area and Its Competitors
Table 111. Cambrex Corporation Pirfenidone API Product Portfolios and Specifications
Table 112. Cambrex Corporation Pirfenidone API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 113. Cambrex Corporation Main Business
Table 114. Cambrex Corporation Latest Developments
Table 115. Glenmark Pharmaceuticals Basic Information, Pirfenidone API Manufacturing Base, Sales Area and Its Competitors
Table 116. Glenmark Pharmaceuticals Pirfenidone API Product Portfolios and Specifications
Table 117. Glenmark Pharmaceuticals Pirfenidone API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 118. Glenmark Pharmaceuticals Main Business
Table 119. Glenmark Pharmaceuticals Latest Developments
Table 120. Macleods Pharmaceuticals Limited Basic Information, Pirfenidone API Manufacturing Base, Sales Area and Its Competitors
Table 121. Macleods Pharmaceuticals Limited Pirfenidone API Product Portfolios and Specifications
Table 122. Macleods Pharmaceuticals Limited Pirfenidone API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 123. Macleods Pharmaceuticals Limited Main Business
Table 124. Macleods Pharmaceuticals Limited Latest Developments
Table 125. Mehta API Basic Information, Pirfenidone API Manufacturing Base, Sales Area and Its Competitors
Table 126. Mehta API Pirfenidone API Product Portfolios and Specifications
Table 127. Mehta API Pirfenidone API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 128. Mehta API Main Business
Table 129. Mehta API Latest Developments
Table 130. Natco Pharma Limited Basic Information, Pirfenidone API Manufacturing Base, Sales Area and Its Competitors
Table 131. Natco Pharma Limited Pirfenidone API Product Portfolios and Specifications
Table 132. Natco Pharma Limited Pirfenidone API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 133. Natco Pharma Limited Main Business
Table 134. Natco Pharma Limited Latest Developments
Table 135. Optimus Pharma Basic Information, Pirfenidone API Manufacturing Base, Sales Area and Its Competitors
Table 136. Optimus Pharma Pirfenidone API Product Portfolios and Specifications
Table 137. Optimus Pharma Pirfenidone API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 138. Optimus Pharma Main Business
Table 139. Optimus Pharma Latest Developments
Table 140. Shilpa Medicare Basic Information, Pirfenidone API Manufacturing Base, Sales Area and Its Competitors
Table 141. Shilpa Medicare Pirfenidone API Product Portfolios and Specifications
Table 142. Shilpa Medicare Pirfenidone API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 143. Shilpa Medicare Main Business
Table 144. Shilpa Medicare Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pirfenidone API
Figure 2. Pirfenidone API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pirfenidone API Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Pirfenidone API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pirfenidone API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 0.99
Figure 10. Product Picture of 0.995
Figure 11. Product Picture of 0.999
Figure 12. Product Picture of Others
Figure 13. Global Pirfenidone API Sales Market Share by Type in 2022
Figure 14. Global Pirfenidone API Revenue Market Share by Type (2018-2023)
Figure 15. Pirfenidone API Consumed in Tablets
Figure 16. Global Pirfenidone API Market: Tablets (2018-2023) & (Tons)
Figure 17. Pirfenidone API Consumed in Capsules
Figure 18. Global Pirfenidone API Market: Capsules (2018-2023) & (Tons)
Figure 19. Pirfenidone API Consumed in Others
Figure 20. Global Pirfenidone API Market: Others (2018-2023) & (Tons)
Figure 21. Global Pirfenidone API Sales Market Share by Application (2022)
Figure 22. Global Pirfenidone API Revenue Market Share by Application in 2022
Figure 23. Pirfenidone API Sales Market by Company in 2022 (Tons)
Figure 24. Global Pirfenidone API Sales Market Share by Company in 2022
Figure 25. Pirfenidone API Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Pirfenidone API Revenue Market Share by Company in 2022
Figure 27. Global Pirfenidone API Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Pirfenidone API Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Pirfenidone API Sales 2018-2023 (Tons)
Figure 30. Americas Pirfenidone API Revenue 2018-2023 ($ Millions)
Figure 31. APAC Pirfenidone API Sales 2018-2023 (Tons)
Figure 32. APAC Pirfenidone API Revenue 2018-2023 ($ Millions)
Figure 33. Europe Pirfenidone API Sales 2018-2023 (Tons)
Figure 34. Europe Pirfenidone API Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Pirfenidone API Sales 2018-2023 (Tons)
Figure 36. Middle East & Africa Pirfenidone API Revenue 2018-2023 ($ Millions)
Figure 37. Americas Pirfenidone API Sales Market Share by Country in 2022
Figure 38. Americas Pirfenidone API Revenue Market Share by Country in 2022
Figure 39. Americas Pirfenidone API Sales Market Share by Type (2018-2023)
Figure 40. Americas Pirfenidone API Sales Market Share by Application (2018-2023)
Figure 41. United States Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Pirfenidone API Sales Market Share by Region in 2022
Figure 46. APAC Pirfenidone API Revenue Market Share by Regions in 2022
Figure 47. APAC Pirfenidone API Sales Market Share by Type (2018-2023)
Figure 48. APAC Pirfenidone API Sales Market Share by Application (2018-2023)
Figure 49. China Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Pirfenidone API Sales Market Share by Country in 2022
Figure 57. Europe Pirfenidone API Revenue Market Share by Country in 2022
Figure 58. Europe Pirfenidone API Sales Market Share by Type (2018-2023)
Figure 59. Europe Pirfenidone API Sales Market Share by Application (2018-2023)
Figure 60. Germany Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Pirfenidone API Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Pirfenidone API Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Pirfenidone API Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Pirfenidone API Sales Market Share by Application (2018-2023)
Figure 69. Egypt Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Pirfenidone API in 2022
Figure 75. Manufacturing Process Analysis of Pirfenidone API
Figure 76. Industry Chain Structure of Pirfenidone API
Figure 77. Channels of Distribution
Figure 78. Global Pirfenidone API Sales Market Forecast by Region (2024-2029)
Figure 79. Global Pirfenidone API Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Pirfenidone API Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Pirfenidone API Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Pirfenidone API Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Pirfenidone API Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Pirfenidone API
Figure 2. Pirfenidone API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pirfenidone API Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Pirfenidone API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pirfenidone API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 0.99
Figure 10. Product Picture of 0.995
Figure 11. Product Picture of 0.999
Figure 12. Product Picture of Others
Figure 13. Global Pirfenidone API Sales Market Share by Type in 2022
Figure 14. Global Pirfenidone API Revenue Market Share by Type (2018-2023)
Figure 15. Pirfenidone API Consumed in Tablets
Figure 16. Global Pirfenidone API Market: Tablets (2018-2023) & (Tons)
Figure 17. Pirfenidone API Consumed in Capsules
Figure 18. Global Pirfenidone API Market: Capsules (2018-2023) & (Tons)
Figure 19. Pirfenidone API Consumed in Others
Figure 20. Global Pirfenidone API Market: Others (2018-2023) & (Tons)
Figure 21. Global Pirfenidone API Sales Market Share by Application (2022)
Figure 22. Global Pirfenidone API Revenue Market Share by Application in 2022
Figure 23. Pirfenidone API Sales Market by Company in 2022 (Tons)
Figure 24. Global Pirfenidone API Sales Market Share by Company in 2022
Figure 25. Pirfenidone API Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Pirfenidone API Revenue Market Share by Company in 2022
Figure 27. Global Pirfenidone API Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Pirfenidone API Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Pirfenidone API Sales 2018-2023 (Tons)
Figure 30. Americas Pirfenidone API Revenue 2018-2023 ($ Millions)
Figure 31. APAC Pirfenidone API Sales 2018-2023 (Tons)
Figure 32. APAC Pirfenidone API Revenue 2018-2023 ($ Millions)
Figure 33. Europe Pirfenidone API Sales 2018-2023 (Tons)
Figure 34. Europe Pirfenidone API Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Pirfenidone API Sales 2018-2023 (Tons)
Figure 36. Middle East & Africa Pirfenidone API Revenue 2018-2023 ($ Millions)
Figure 37. Americas Pirfenidone API Sales Market Share by Country in 2022
Figure 38. Americas Pirfenidone API Revenue Market Share by Country in 2022
Figure 39. Americas Pirfenidone API Sales Market Share by Type (2018-2023)
Figure 40. Americas Pirfenidone API Sales Market Share by Application (2018-2023)
Figure 41. United States Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Pirfenidone API Sales Market Share by Region in 2022
Figure 46. APAC Pirfenidone API Revenue Market Share by Regions in 2022
Figure 47. APAC Pirfenidone API Sales Market Share by Type (2018-2023)
Figure 48. APAC Pirfenidone API Sales Market Share by Application (2018-2023)
Figure 49. China Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Pirfenidone API Sales Market Share by Country in 2022
Figure 57. Europe Pirfenidone API Revenue Market Share by Country in 2022
Figure 58. Europe Pirfenidone API Sales Market Share by Type (2018-2023)
Figure 59. Europe Pirfenidone API Sales Market Share by Application (2018-2023)
Figure 60. Germany Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Pirfenidone API Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Pirfenidone API Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Pirfenidone API Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Pirfenidone API Sales Market Share by Application (2018-2023)
Figure 69. Egypt Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Pirfenidone API Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Pirfenidone API in 2022
Figure 75. Manufacturing Process Analysis of Pirfenidone API
Figure 76. Industry Chain Structure of Pirfenidone API
Figure 77. Channels of Distribution
Figure 78. Global Pirfenidone API Sales Market Forecast by Region (2024-2029)
Figure 79. Global Pirfenidone API Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Pirfenidone API Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Pirfenidone API Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Pirfenidone API Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Pirfenidone API Revenue Market Share Forecast by Application (2024-2029)
